Citigroup
AUPH icon

Citigroup’s Aurinia Pharmaceuticals AUPH Stock Holding History

Citigroup’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-50,000
Closed -$424K – 6079
2025
Q2 		$424K Buy
+50,000
New +$401K ﹤0.01% 3728
2025
Q1 		– Sell
-50,000
Closed -$449K – 5573
2024
Q4 		$449K Buy
50,000
+30,000
+150% +$245K ﹤0.01% 3905
2024
Q3 		$147K Sell
20,000
-29,900
-60% -$185K ﹤0.01% 4567
2024
Q2 		$285K Hold
49,900
– – ﹤0.01% 3709
2024
Q1 		$250K Buy
+49,900
New +$339K ﹤0.01% 3905
2023
Q4 		– Sell
-40,000
Closed -$311K – 5695
2023
Q3 		$311K Sell
40,000
-9,900
-20% -$96.8K ﹤0.01% 3398
2023
Q2 		$483K Buy
+49,900
New +$518K ﹤0.01% 3404

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return